Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCVUnderstanding the Growing Syndemic — Opioids, HCV, and HIV
Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection.
Allyn PR, et al. Int J STD AIDS. 2018;29(4):334-340.
Chhatwal J, et al. Aliment Pharmacol Ther. 2018;47(7):1023-1031.
Debes JD, et al. J Clin Transl Hepatol. 2016;4(4):328-335.
High rates of unprotected anal sex and use of generic direct-acting antivirals in a cohort of MSM with acute HCV infection.
Girometti N, et al. J Viral Hepat. 2019;26(6):627-634.
Medical and behavioral approaches to engage people who inject drugs into care for hepatitis C virus infection.
Gonzalez SA, et al. Addict Disord Their Treat. 2017;16(2 suppl 1):S1-S23.
Grebely J, Dore GJ. Clin Liver Dis. 2017;9(4):77-80.
Changing the odds: motives for and barriers to reducing HCV-related sexual risk behavior among HIV-infected MSM previously infected with HCV.
Lambers F, et al. BMC Infect Dis. 2018;18(1):678.
Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals.
Rich ZC, et al. BMC Public Health. 2016;16:994.
Understanding the Growing Syndemic —Opioids, HCV, and HIV
The PCPs Role in Preventing HIV
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis
What Do You Know About PrEP?
Got it? Treat it!
The Critical Role of the Community Pharmacist
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
The Emerging Role of the Diabetologist
Key Issues Impacting OB/GYN Practice
An Interactive Experience Highlighting Recent Clinical Advances
Hot Topics in HBV, HCV, and NASH
Emerging Concepts in Patient Management
Building Your Understanding to Combat a Growing Problem
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Why It Matters in OB/GYN Practice Today
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
How the Pharmacist Can Make a Difference
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Appraising the Therapeutic Armamentarium in Moderate and Severe Disease
A PrEP Primer
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
The Rapid ART Standard of Care: From Evidence to Healthcare Equity
Maximizing Your Role to Impact Patient Outcomes
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Benefits, Barriers, & Best Practices in an Advancing Field
Practical Solutions Across the Spectrum of Care
A PEP/PrEP Training Guide for Pharmacists
An Interactive Learning Experience